Effect of Sit-to-Stand Intervention in the Intensive Care Unit Survivors
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Nov 17, 2020
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the Clinical Trial: Effect of Sit-to-Stand Intervention in ICU Survivors**
This clinical trial is studying a special program called "Sit-to-Stand Care" designed for people who have recently recovered from intensive care unit (ICU) treatment and find it difficult to sit up or stand on their own. Sitting up and standing are important skills for living independently and participating in daily activities. Unfortunately, many ICU survivors struggle with these skills even after leaving the hospital. This study aims to see if the Sit-to-Stand Care can help improve their ability to sit and stand, enhance their physical strength, and reduce the chances of being bed-bound or facing serious health issues within a year after leaving the ICU.
To be eligible for this trial, participants must be at least 20 years old, have been in the ICU for more than two days, and be unable to sit up or stand by the time they are discharged from the ICU. Participants will receive either the Sit-to-Stand Care program, which includes daily exercises and practice under the guidance of a trained nurse, or the usual care they would normally receive. Throughout the study, their progress will be monitored at several points to see how well they improve in terms of their physical abilities and overall health. This trial has received approval from the ethics committee, ensuring that the study is safe and respects the rights of the participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 20 years or older.
- • Admitted for ICU treatment \> 2 days.
- • Unable to sit-to-stand by ICU discharge.
- Exclusion Criteria:
- • Unable to follow command.
- • Bedridden before index hospitalization.
- • Ventilator dependent after ICU discharge .
- • Received palliative care.
- • Co-morbidities of the trunk or lower limbs unable to ambulate due to neuromuscular or musculoskeletal etiology (e.g. CVA, spinal cord injury, amputation or fracture of lower limb).
- • Placed on droplet or contact precausion (e.g. Open TB, SARS, COVID-19 )
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, National Taiwan University Hospital, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials